In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
We review Bayesian and Bayesian decision theoretic approaches to subgroup analysis and applications to subgroup-based adaptive clinical trial designs. Subgroup analysis refers to inference about ...
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
In the ever-evolving toolkit of statistical analysis techniques, Bayesian statistics has emerged as a popular and powerful methodology for making decisions from data in the applied sciences. Bayesian ...
Disclaimer: This Working Paper should not be reported as representing the views of the IMF.The views expressed in this Working Paper are those of the author(s) and do not necessarily represent those ...
This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American I’m not sure when I first heard of Bayes’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results